Optra Systems, a Pune-based software solutions provider, announced the launch of ‘OPTRA Health’, a unit dedicated entirely to research and development (R&D) in the field of biomedical engineering, in Pune.  While making the announcement at a press conference held in the city, founder-president and CEO of OPTRA Systems, Abhijeet Gholap, said that  Dr Gauri Gholap will head this unit of OPTRA Health. 

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Abhijeet said, “OPTRA Health will leverage its strong R&D background and expertise to develop biomedical devices for the global market as a part of outsourced product development for its overseas clients, and would also focus on creating its own intellectual property in this domain.” 

“Core research on Gene-Diseases to aid the Human Genome Project, medical instrumentation for cancer imaging, computer-aided diagnostic tools and cloud-based ‘Pay-as-you-go’ lab information management system (LIMS) have been identified as the four main areas in which OPTRA Health will work,” he added. The new state-of-the-art R&D lab has come up on 13,500 square feet with a product lab, a bio lab and a digital oncology lab. 

It would have a dedicated research team of over 165 professionals with an ambitious target of filing at least 5 international patents within 2 years of operations. 

The company would invest over USD 3 million in the next 18 months in this R&D unit for infrastructure and manpower.  Considering the strong R&D background of OPTRA Systems, the department of scientific and industrial research (DSIR), Government of India, has recognised OPTRA Health lab as an R&D Unit for healthcare and life sciences. 

With the recognition by the government, OPTRA Health would be entitled to undertake R&D projects under the biotech industry partnership programme (BIPP) of DSIR for affordable healthcare technologies and products in the field of diagnostics and biomedical devices.